Discovery of ETX2514, a novel, rationally designed inhibitor of class A, C and D β-lactamases, for the treatment of Gram-negative infections

Thomas Durand-reville

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com